FDA removes black box warning from three estradiol transdermal patches for menopause
The U.S. Food and Drug Administration approved the removal of black box warnings from three estradiol transdermal patches used to treat menopause symptoms. The strictest FDA warnings had previously cautioned about risks of cardiovascular disease, breast cancer, and dementia.
